EUVIMEDEUVIMED entdecken
Open Access

NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

Tommy Weiss-Sadan, Maolin Ge, Makiko Hayashi, Magdy Gohar, Cong-Hui Yao, Adriaan de Groot, Stefan Harry, Alexander Carlin, Hannah Fischer, Lei Shi, Ting-Yu Wei, Charles H Adelmann und 15 weitere

Cell Metabolism · 2023-03 · 35 (3) · 487-503.e7

DOI: 10.1016/j.cmet.2023.01.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2023-03. Verfasst von Tommy Weiss-Sadan und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, NF-E2-Related Factor 2. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAMS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple cancers regulate oxidative stress by activating the transcription factor NRF2 through mutation of its negative regulator, KEAP1. NRF2 has been studied extensively in KEAP1-mutant cancers; however, the role of this pathway in cancers with wild-type KEAP1 remains poorly understood. To answer this question, we induced NRF2 via pharmacological inactivation of KEAP1 in a panel of 50+ non-small cell lung cancer cell lines. Unexpectedly, marked decreases in viability were observed in >13% of the cell lines-an effect that was rescued by NRF2 ablation. Genome-wide and targeted CRISPR screens revealed that NRF2 induces NADH-reductive stress, through the upregulation of the NAD+-consuming enzyme ALDH3A1. Leveraging these findings, we show that cells treated with KEAP1 inhibitors or those with endogenous KEAP1 mutations are selectively vulnerable to Complex I inhibition, which impairs NADH oxidation capacity and potentiates reductive stress. Thus, we identify reductive stress as a metabolic vulnerability in NRF2-activated lung cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNF-E2-Related Factor 2HumansCell Line, TumorKelch-Like ECH-Associated Protein 1NADOxidative StressSignal Transduction

Stichwörter der Autor:innen

NADH/NAD(+)NRF2-KEAP1 pathwayfunctional genomicnon-small cell lung canceroxidative phosphorylationreductive stress

Substanzen

Kelch-Like ECH-Associated Protein 1NADNF-E2-Related Factor 2NFE2L2 protein, human

Autor:innen und Institutionen

  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mge1@mgh.harvard.edu.
  • Department of Pathology, New York University Grossman School of Medicine, 550 First Avenue, New York, NY 10016, USA; Laura and Isaac Pelmutter Cancer Center, New York University Langone Health, New York, NY 10016, USA.
  • Department of Cell Biology, Blavatnik Institute Harvard Medical School, Boston, MA 02115, USA.
  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02114, USA.

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • NIGMS NIH HHS
  • Sächsische Aufbaubank
  • Massachusetts Life Sciences Center
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • American Cancer Society
  • Melanoma Research Alliance

Zitieren

APA

Weiss-Sadan, T., Ge, M., Hayashi, M., Gohar, M., Yao, C. H., de Groot, A., Harry, S., Carlin, A., Fischer, H., Shi, L., Wei, T. Y., Adelmann, C. H., Wolf, K., Vornbäumen, T., Dürr, B. R., Takahashi, M., Richter, M., Zhang, J., Yang, T. Y., …, & Bar-Peled, L. (2023). NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer. Cell Metabolism, 35(3), 487-503.e7. https://doi.org/10.1016/j.cmet.2023.01.012

Vancouver

Weiss-Sadan T, Ge M, Hayashi M, Gohar M, Yao CH, de Groot A, et al. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer. Cell Metabolism. 2023;35(3):487-503.e7. doi:10.1016/j.cmet.2023.01.012

BibTeX
@article{WeissSadan2023,
  author = {Weiss-Sadan, Tommy and Ge, Maolin and Hayashi, Makiko and Gohar, Magdy and Yao, Cong-Hui and de Groot, Adriaan and Harry, Stefan and Carlin, Alexander and Fischer, Hannah and Shi, Lei and Wei, Ting-Yu and Adelmann, Charles H and Wolf, Konstantin and Vornbäumen, Tristan and Dürr, Benedikt R and Takahashi, Mariko and Richter, Marianne and Zhang, Junbing and Yang, Tzu-Yi and Vijay, Vindhya and Fisher, David E and Hata, Aaron N and Haigis, Marcia C and Mostoslavsky, Raul and Bardeesy, Nabeel and Papagiannakopoulos, Thales and Bar-Peled, Liron},
  title = {NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer},
  journal = {Cell Metabolism},
  year = {2023},
  volume = {35},
  number = {3},
  pages = {487--503.e7},
  doi = {10.1016/j.cmet.2023.01.012}
}
Kostenlos starten →